Rallis India (RALLIS) investor relations material

Executive summary

• Q4 FY 2026 revenue grew 6% year-over-year to INR 456 crore, with EBITDA improving by 96% to INR -1 crore and PAT at INR -15 crore, a 52% improvement over last year.

• Full-year revenue reached INR 2,897 crore, up 9% year-over-year, with strong growth in Crop Care, Seeds, and Soil & Plant Health segments.

• Achieved record-high EBITDA for FY26, driven by broad-based volume growth, cost optimization, and new product launches across segments.

• Domestic formulations delivered 5% revenue growth despite adverse weather and lower pest pressure.

• Audited financial results for the year ended March 31, 2026, were approved with an unmodified audit opinion from statutory auditors.

Financial highlights

• FY26 revenue increased by 9% year-over-year to ₹2,897 Cr; Q4 revenue up 6% YoY to ₹456 Cr.

• FY26 EBITDA rose 26% YoY to ₹362 Cr, marking the highest ever; Q4 EBITDA improved 96% YoY.

• FY26 PAT grew 47% YoY to ₹184 Cr; Q4 PAT improved 52% YoY but remained negative at -₹15 Cr.

• Crop Care FY26 revenue up 8% YoY to ₹2,416 Cr; Seeds FY26 revenue up 15% YoY to ₹481 Cr.

• Basic and diluted EPS for FY 2025-26 was ₹9.46, up from ₹6.43 year-over-year.

Outlook and guidance

• Margins expected to remain stable to soft due to cost inflation and supply chain disruptions.

• Focus on widening reach, extending portfolio, and intensifying custom synthesis, with enhanced cost competitiveness and digital interventions.

• High double-digit growth anticipated in seeds, driven by cotton, maize, and rice.

• Business is seasonal and performance can be impacted by weather and cropping patterns.

• Price increases announced to offset 15%-25% raw material cost inflation, with ability to pass on costs dependent on market conditions.